Global Animal Vaccines Market 2018-2022 - Key Vendors are Bayer, Eli Lilly (Elanco Animal Health), Merck & Boehringer Ingelheim - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “Global Animal Vaccines Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The Global Animal Vaccines Market to grow at a CAGR of 4.84% during the period 2018-2022.
Global Animal Vaccines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the retail sales of animal vaccines across the globe.
Animal vaccines are biological preparations used to stimulate the immune system of animals to develop adaptive immunity to a pathogen. All animal vaccines undergo regulatory approval processes, the same as human vaccines, before they gain a product license for sale.
One trend affecting this market are the different vaccine delivery routes based on the target species. The development of animal vaccines is not only influenced by the type of antigens but also by the route of administration.
According to the report, one driver influencing this market is the increase in demand for livestock products. The increase in the consumption of livestock products such as meat, milk, and eggs are expected to drive the growth of the global animal vaccines market.
Further, the report states that one challenge affecting this market are the difficulties associated with animal vaccine storage and handling. Animal vaccines require a strictly maintained cold chain logistics and most developing countries require huge investments to maintain effective cold chain logistics and a proper vaccine management system.
Key vendorsBayer Eli Lilly (Elanco Animal Health) Merck Boehringer Ingelheim
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 05: MARKET SIZINGMarket definition Market sizing 2017 Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSISBargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition
PART 07: APPROVED ANIMAL VACCINESLeading approved animal vaccines
PART 08: MARKET SEGMENTATION BY VACCINE TYPESegmentation by vaccine type Comparison by vaccine type Inactivated vaccines Live attenuated vaccines Recombinant vaccines Toxoid vaccines DNA vaccines Market opportunity by vaccine type
PART 09: MARKET SEGMENTATION BY APPLICATIONSegmentation by application Porcine vaccines Poultry vaccines Livestock vaccines Companion animal vaccines Aquaculture and other vaccines
PART 10: CUSTOMER LANDSCAPE
PART 11: REGIONAL LANDSCAPEGeographical segmentation Regional comparison Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
PART 14: MARKET TRENDSDifferent vaccine delivery routes based on the target species Increasing adoption of companion animals Changing landscape of the infectious diseases in animals Multiple purposes of veterinary vaccination
PART 15: VENDOR LANDSCAPE
PART 16: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors
For more information about this report visit https://www.researchandmarkets.com/research/2fv8h7/global_animal?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005731/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Animal Pharmaceuticals
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/07/2018 12:24 PM/DISC: 11/07/2018 12:24 PM